Patents by Inventor Lin Kang

Lin Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210096281
    Abstract: The present invention relates to a hard coating film including a substrate and a hard coating layer provided on at least one surface of the substrate, the hard coating layer including a cured product of a hard coating composition containing a fluorine-based UV-curable-functional-group-containing compound, a light-transmissive resin, and a fluorine-based solvent, and the fluorine-based solvent is contained in an amount of 0.1 to 40 wt % based on a total of 100 wt % of the hard coating composition, and to a window and an image display device using the same.
    Type: Application
    Filed: September 29, 2020
    Publication date: April 1, 2021
    Inventors: Seung-Hee Kim, Geo-San Lim, Min-Kyung Kang, Hye-Lin Kim
  • Publication number: 20210094266
    Abstract: The present invention relates to a hard coating film including a substrate and a hard coating layer provided on at least one surface of the substrate, the hard coating layer having a surface resistance of 108 to 1012 ?/? and a water contact angle of 100° or more, and to a window and an image display device using the same.
    Type: Application
    Filed: September 29, 2020
    Publication date: April 1, 2021
    Inventors: Min-Kyung Kang, Geo-San Lim, Seung-Hee Kim, Hye-Lin Kim
  • Publication number: 20210095137
    Abstract: The present invention relates to a hard coating film including a substrate and a hard coating layer provided on at least one surface of the substrate, in which the hard coating layer includes a cured product of a hard coating composition containing a fluorine-based UV-curable-functional-group-containing compound, dendritic acrylate, a conductive polymer, and a solvent, the conductive polymer being included in a specific amount, whereby the hard coating film is applicable to a flexible display device and can simultaneously exhibit hard coating performance and antifouling performance even in the form of a single layer that does not include a separate antifouling layer, and in particular, the high antifouling effect can be maintained even in the presence of variously changing environmental conditions, and to a window and an image display device using the same.
    Type: Application
    Filed: September 29, 2020
    Publication date: April 1, 2021
    Inventors: Geo-San Lim, Min-Kyung Kang, Seung-Hee Kim, Hye-Lin Kim
  • Patent number: 10965485
    Abstract: An agent analysis system includes a terminal product system, a remote diagnosis system (RDS), and an agent analyzer. The terminal product system is supplied with a power source and provided with a current sensor to sense the power source. The RDS is used to transmit at least one control instruction via internet for the terminal product system. They agent analyzer is used to communicate with the terminal product system and the RDS, and configured to measure and analyze the electricity use characteristics of the terminal product system to be transmitted to the RDS; and receive and convert the control instruction from the RDS via internet for the terminal product system.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: March 30, 2021
    Assignee: DARTPOINT TECH. CO., LTD.
    Inventors: Chi-Lin Kang, Chao-Yuan Huang
  • Patent number: 10947179
    Abstract: The disclosure relates to a compound, 2-(3,4-dihydroxyphenyl)ethyl 3-hydroxybutanoate, for improving aortic endothelial cell function and use thereof. The compound is capable of inhibiting inflammatory response of the human aortic endothelial cells caused by a saturated fatty acid, and preventing an occurrence and progression of atherosclerosis. The compound is capable of reducing human aortic endothelial inflammation caused by a saturated fatty acid, for example, reducing the mRNA levels of interleukin-6 (IL-6), and is capable of effectively protecting the function of mitochondria in human aortic endothelium from being damaged by a saturated fatty acid, for example, increasing the expression of mitochondrial complex I.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: March 16, 2021
    Assignee: XI'AN JIAOTONG UNIVERSITY
    Inventors: Jian-Kang Liu, Xu-Yun Liu, Ya-Chong Hu, Lin Zhao, Yong-Yao Wang, Cai-Yue Zhu, Zhen Wang, Jing Lou, Qing-Qing Ma, Yu-Xia Zhang, Qing-Lin Jiang, Xiao-Hong Xu, Ting-Hua Zhang, Jian-Gang Long
  • Publication number: 20210047262
    Abstract: The disclosure relates to a compound, 2-(3,4-dihydroxyphenyl)ethyl 3-hydroxybutanoate, for improving aortic endothelial cell function and use thereof. The compound is capable of inhibiting inflammatory response of the human aortic endothelial cells caused by a saturated fatty acid, and preventing an occurrence and progression of atherosclerosis. The compound is capable of reducing human aortic endothelial inflammation caused by a saturated fatty acid, for example, reducing the mRNA levels of interleukin-6 (IL-6), and is capable of effectively protecting the function of mitochondria in human aortic endothelium from being damaged by a saturated fatty acid, for example, increasing the expression of mitochondrial complex I.
    Type: Application
    Filed: September 26, 2019
    Publication date: February 18, 2021
    Applicant: XI'AN JIAOTONG UNIVERSITY
    Inventors: JIAN-KANG LIU, XU-YUN LIU, YA-CHONG HU, LIN ZHAO, YONG-YAO WANG, CAI-YUE ZHU, ZHEN WANG, JING LOU, QING-QING MA, YU-XIA ZHANG, QING-LIN JIANG, XIAO-HONG XU, TING-HUA ZHANG, JIAN-GANG LONG
  • Publication number: 20210032596
    Abstract: Provided herein are methods of producing erythrocytes from hematopoietic cells, particularly hematopoietic cells from placental perfusate in combination with hematopoietic cells from umbilical cord blood, wherein the method results in accelerated expansion and differentiation of the hematopoietic cells to more efficiently produce administrable erythrocytes. Further provided herein is a bioreactor in which hematopoietic cell expansion and differentiation takes place.
    Type: Application
    Filed: March 12, 2020
    Publication date: February 4, 2021
    Applicant: Celularity, Inc.
    Inventors: Mohammad A. Heidaran, Xiaokui Zhang, Lin Kang, Andrew Zeitlin, Vanessa Voskinarian-Berse, Stewart Abbot
  • Publication number: 20210008109
    Abstract: Provided herein are methods of treating a hematological disorder, a solid tumor, or an infectious disease in a subject in need thereof using natural killer cells in combination with a second agent, or using natural killer cells with genetic modifications for target specificity and/or homing specificity.
    Type: Application
    Filed: February 18, 2020
    Publication date: January 14, 2021
    Applicant: CELGENE CORPORATION
    Inventors: Lin KANG, Xiaokui ZHANG, Jeffrey HARRIS, Vladimir JANKOVIC
  • Publication number: 20200397718
    Abstract: The present disclosure discloses use of hydroxytyrosol acetate in preparation of a medicament for improving aortic endothelial cell function. The hydroxytyrosol acetate is capable of inhibiting an inflammation of aortic endothelial cells caused by a saturated fatty acid, reducing mRNA levels corresponding to matrix metalloproteinase-1 (MMP-1), intercellular adhesion molecule-1 (ICAM-1) and plasma plasminogen activator inhibitor-1 (PAI-1) in aortic endothelial cells and protecting mitochondria from being damaged by inflammation of aortic endothelial cells caused by a saturated fatty acid, preventing the occurrence and development of atherosclerosis by anti-inflammatory and protecting mitochondrial function.
    Type: Application
    Filed: June 10, 2020
    Publication date: December 24, 2020
    Inventors: JIAN-KANG LIU, XU-YUN LIU, XIAO-JIE WANG, YUE XIONG, LIN ZHAO, CAI-YUE ZHU
  • Patent number: 10854450
    Abstract: The present disclosure describes patterned devices and methods for repairing substrate lattice damage in a patterned device. The patterned device includes a substrate, an alternating conductor and dielectric stack atop the substrate, a channel hole extending through the alternating conductor and dielectric stack to the substrate, and an epitaxial grown layer at a bottom of the channel hole and a top surface of the substrate. A part of the substrate in contact with the epitaxial grown layer has a dopant or doping concentration different from an adjacent part of the substrate. The method includes forming a channel hole in an insulating layer atop a substrate, forming an amorphous layer in a top side of the substrate below the channel hole, heating to crystallize the amorphous layer, and growing an epitaxial layer on the crystallized layer in the channel hole.
    Type: Grant
    Filed: October 17, 2019
    Date of Patent: December 1, 2020
    Assignee: Yangtze Memory Technologies Co., Ltd.
    Inventors: Xiao Jun Wang, Wei Zhou, Lin Kang Xu, Guan Nan Li
  • Publication number: 20200370793
    Abstract: A sealing structure for a Stirling cooler includes a bellows, a first connecting block disposed at an end of the bellows, and a second connecting block disposed at another end of the bellows. The sealing structure for a Stirling cooler can generate both off-axis movements and lateral movements so as to produce corresponding harmonic motions, such that vibrations can be isolated, excellent vacuum can be obtained, and superior sealing quality can be ensured. Thereupon, possible leakage for the Stirling cooler operated under a significant pressure difference can be substantially resolved.
    Type: Application
    Filed: July 18, 2019
    Publication date: November 26, 2020
    Inventors: SHUNG-WEN KANG, CHUN-LIN CHANG
  • Patent number: 10846324
    Abstract: A method for content processing, including: classifying a plurality of media content items into corresponding categories; determining, based at least in part on a category, a content label and display information associated with the content label, wherein: the category corresponds to an item of media content; the content label corresponds to the category; and the display information indicates a display area for displaying the content label on a display interface; and displaying the content label based at least in part on the display information on the display interface.
    Type: Grant
    Filed: July 27, 2018
    Date of Patent: November 24, 2020
    Assignee: Alibaba Group Holding Limited
    Inventors: Junwen Zhang, Lin Kang, Yan Cheng
  • Patent number: 10823628
    Abstract: A device to sense degree of twist in a screwdriver and the magnitude of force applied includes a contacting portion, a deformation portion, a sensing portion, and a processor. The contacting portion receives a grip and twist pressure through the deformation portion which is tiltedly fixed to the contacting portion. The deformation portion carries the sensing portion and elastically deforms under the force and/or the torsion. The sensing portion detects a deformation of the deformation portion and generates a corresponding electrical signal. The processor receives the signal and determines the values of the twist caused and the force applied.
    Type: Grant
    Filed: March 13, 2019
    Date of Patent: November 3, 2020
    Assignees: HONGFUJIN PRECISION ELECTRONICS (ZHENGZHOU) CO., LTD., HON HAI PRECISION INDUSTRY CO., LTD.
    Inventors: Eddy Liu, Po-Lin Su, Jie-Peng Kang, Xue-Rui Deng, Liu-Ming Zhang, Wei-Wei Hao, Su-Min Li, Guang-Xing Wang, Rui Li, Jie Lai
  • Publication number: 20200330516
    Abstract: Provided herein are methods of producing natural killer (NK) cells using a three-stage expansion and differentiation method with media comprising stem cell mobilizing factors. Also provided herein are methods of suppressing tumor cell proliferation using the NK cells and the NK cell populations produced by the three-stage methods described herein, as well as methods of treating individuals having cancer or a viral infection, comprising administering the NK cells and the NK cell populations produced by the three-stage methods described herein to an individual having the cancer or viral infection.
    Type: Application
    Filed: May 18, 2020
    Publication date: October 22, 2020
    Applicant: Celularity Inc.
    Inventors: Brian MURPHY, Vanessa VOSKINARIAN-BERSE, Andrea NORDBERG, Keith WILSON, Lin KANG
  • Patent number: 10789335
    Abstract: A remote diagnosis management system is utilized for a plurality of massage bath devices and includes at least one processor executing steps of: receiving a remote trigger event of each of the massage bath devices, wherein the remote trigger event is generated by a control unit of each of the massage bath devices or by at least one of a maintenance-worker and a user of each of the massage bath devices; analyzing the remote trigger event to generate an analyzed result; remotely operating at least one state of each of the massage bath devices according to the analyzed result; requesting authorization from the user of each of the massage bath devices before the step of remotely operating the at least one state of each of the massage bath devices; and scheduling at least one remote diagnosis of the massage bath devices.
    Type: Grant
    Filed: November 24, 2016
    Date of Patent: September 29, 2020
    Assignee: DARTPOINT TECH. CO., LTD.
    Inventors: Chi-Lin Kang, Ai-Chieh Lu, Chao-Yuan Huang
  • Publication number: 20200276252
    Abstract: The present disclosure provides an isolated recombinant oncolytic adenovirus, a pharmaceutical composition, and uses thereof for drugs for treatment of tumors and/or cancers. The recombinant oncolytic adenovirus is a selectively replicating oncolytic adenovirus, and the genome of the recombinant oncolytic adenovirus is integrated with a coding sequence of exogenous shRNA capable of inhibiting PDL1 expression in tumor cells. The replication capability of the virus in normal primary cells is much lower than the replication capability of the virus in tumor cells. Moreover, the expressed shPDL1 can significantly reduce the level of PDL1 protein highly expressed in tumor cells. Thus, the oncolytic killing effect of the oncolytic virus and the anti-tumor immunostimulatory effect of immune cells produce a synergistic effect.
    Type: Application
    Filed: July 3, 2018
    Publication date: September 3, 2020
    Inventors: Jipo SHENG, Jin FU, Ronghua ZHAO, Yun QIN, Lin CHEN, Sanmao KANG, Fang HU
  • Patent number: 10760649
    Abstract: A speed reducer includes an input shaft, an output shaft, and a gear assembly coupled to the input shaft. The gear assembly includes a housing, an external gear, and at least two internal gears. The external gear is located within the housing and inscribes the at least two internal gears. One side of the at least two internal gears is rotatably coupled to the input shaft, and another side of the at least two internal gears is coupled to a connecting column of the output shaft. The at least two internal gears are offset on the input shaft, and the input shaft drives the at least two internal gears to maintain engagement with the external gear. The connecting column maintains transmission of the output shaft and the at least two internal gears.
    Type: Grant
    Filed: July 18, 2018
    Date of Patent: September 1, 2020
    Assignees: HONGFUJIN PRECISION ELECTRONICS (ZHENGZHOU) CO., LTD., HON HAI PRECISION INDUSTRY CO., LTD.
    Inventors: Eddy Liu, Wei-Da Yang, Po-Lin Su, Jie-Peng Kang, Liu-Ming Zhang, Su-Min Li, Guang-Xing Wang, Jie Lai
  • Publication number: 20200246393
    Abstract: Provided herein are methods of suppressing the growth or proliferation of tumor cells and methods of treating individuals having tumor cells using placental perfusate, placental perfusate cells, placenta-derived intermediate natural killer (PINK) cells, combined natural killer (NK) cells, or combinations thereof, in combination with an antibody (e.g., anti-disialoganglioside (anti-GD2) antibody). Also provided herein are compositions comprising placental perfusate, placental perfusate cells, PINK cells, combined NK cells, or combinations thereof, in combination with an antibody (e.g., anti-GD2 antibody).
    Type: Application
    Filed: September 27, 2018
    Publication date: August 6, 2020
    Applicant: CELULARITY, INC.
    Inventors: Xiaokui ZHANG, Lin KANG, Robert J. HARIRI
  • Publication number: 20200223833
    Abstract: The present invention relates to the compounds according to Formula (1), the racemates, enantiomers, diastereomers thereof or pharmaceutical acceptable salts thereof, or pharmaceutical compositions comprising these, for the treatment or prevention of metabolic disorders. The compounds according to Formula (1) are, as GPR40 agonists, available for oral administration with glucose-dependent insulin secretion mechanism, which exhibit excellent glucose lowering efficacy without the risk of hypoglycemia. Thus, the compounds and/or pharmaceutical compositions comprising the compounds as effective components are useful in treating and/or preventing symptoms of type 2 diabetes through adequate control of blood glucose.
    Type: Application
    Filed: December 14, 2017
    Publication date: July 16, 2020
    Inventors: Jae-Hoon Kang, Hong-Sub Lee, Kyung-Mi An, Chang-Hee Hong, Hyun-Jung Kwak, Shuo-Lin Cui, Hyo-Jung Song
  • Publication number: 20200220050
    Abstract: A light emitting diode (LED) including an epitaxial stacked layer, first and second reflective layers which are disposed at two sides of the epitaxial stacked layer, a current conducting layer and first and second electrodes and a manufacturing thereof are provided. The epitaxial stacked layer includes a first-type and a second-type semiconductor layers and an active layer. A main light emitting surface with a light transmittance >0% and ?10% is formed on one of the two reflective layers. The current conducting layer contacts the second-type semiconductor layer. The first electrode is electrically connected to the first-type semiconductor layer. The second electrode is electrically connected to the second-type semiconductor layer via the current conducting layer. A contact scope of the current conducting layer and the second-type semiconductor layer is served as a light-emitting scope overlapping the two layers, but not overlapping the two electrodes.
    Type: Application
    Filed: December 6, 2019
    Publication date: July 9, 2020
    Applicant: Genesis Photonics Inc.
    Inventors: Yi-Ru Huang, Kai-Shun Kang, Tung-Lin Chuang, Yu-Chen Kuo, Yan-Ting Lan, Chih-Ming Shen, Jing-En Huang